BIOLASE, Inc. (NASDAQ:BIOL – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 815,700 shares, a growth of 219.5% from the April 15th total of 255,300 shares. Based on an average daily volume of 1,030,000 shares, the short-interest […]
/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31,.
Equities researchers at StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research report issued on Monday. The brokerage set a “sell” rating on the medical technology company’s stock. A number of other equities analysts also recently issued reports on BIOL. Lake Street Capital reaffirmed a “buy” rating on shares of […]
StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research note released on Sunday. The firm issued a sell rating on the medical technology company’s stock. Several other research analysts have also recently issued reports on the company. Lake Street Capital restated a buy rating on shares of BIOLASE in a […]